NCT02541201

Brief Summary

This is a randomized, double-blind, single-center, two-arm, placebo-controlled clinical trial that examine the effect of the consumption of a plant sterols-enriched low-fat milk. Half of the participants will consume of 1.5g of plant sterols daily as provided by two servings of the plant sterols-enriched low-fat milk product for 3 consecutive weeks, while the other half will consume placebo low-fat milk.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
221

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Aug 2015

Shorter than P25 for phase_2

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2015

Completed
25 days until next milestone

First Submitted

Initial submission to the registry

August 26, 2015

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2015

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 4, 2015

Completed
Last Updated

October 14, 2015

Status Verified

October 1, 2015

Enrollment Period

1 month

First QC Date

August 26, 2015

Last Update Submit

October 12, 2015

Conditions

Keywords

Plant sterolsLow-Density Lipoprotein CholesterolPhytosterols

Outcome Measures

Primary Outcomes (1)

  • Mean of serum low-density lipoprotein cholesterol (LDL-C)

    From baseline to week 3

Secondary Outcomes (6)

  • Change of serum LDL-C

    From baseline to week 3

  • Change of high-density lipoprotein cholesterol (HDL-C)

    From baseline to week 3

  • Change of total cholesterol

    From baseline to week 3

  • Change of triglycerides (TAG)

    From baseline to week 3

  • Change of serum creatinine

    From baseline to week 3

  • +1 more secondary outcomes

Study Arms (2)

Plant sterols-enriched low-fat milk

EXPERIMENTAL

Daily consumption of 1.5g of plant sterols as provided by two servings of 273 ml of plant sterols-enriched low-fat milk for consecutive 3 weeks, each serving taken right before breakfast and lunch.

Dietary Supplement: Plant sterols-enriched low-fat milk

Low-fat milk

PLACEBO COMPARATOR

Daily consumption of two servings of 273 ml of low-fat milk (without plant sterols) for consecutive 3 weeks, each serving taken right before breakfast and lunch.

Dietary Supplement: Low-fat milk

Interventions

The study product is a dried partly skimmed milk powder with no more than 12% milk fat (11.4g total fat/100g product) containing unesterified, unhydrogenated plant sterols.

Plant sterols-enriched low-fat milk
Low-fat milkDIETARY_SUPPLEMENT

The placebo product is a dried partly skimmed milk powder.

Low-fat milk

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Southern Chinese male or female ≥ 18years.
  • In good general health as evidenced by medical history
  • Have the ability to understand the requirements of the study, provide written informed consent, including consent for the use and discloser of research-related health information, and comply with the study data collection procedures. Provide signed and dated informed consent form

You may not qualify if:

  • Subject with familial hypercholesterolemia
  • Ingestion of drugs known to interfere with lipid profiles, such as hormone replacement treatment, diuretics, beta-blockers, statin or other hypochoelsterolemic drug treatment
  • Smoking \> 10 cigarettes/day
  • Subject with heavy alcohol intake (Alcohol \> 3 glasses wine, or 2 beers, or 1 shot hard alcohol/day)
  • Having milk intolerance or dislike
  • Having major diseases such as diabetes (type I and type II), renal or liver diseases
  • Subject presenting known allergy or hypersensitivity to milk proteins, soy and peanut
  • Subject refusing to stop the consumption of plant sterols-enriched products if any during the study (other than the studied product)
  • Subject receiving systemic treatment or topical treatment likely to interfere with evaluation of the study parameters
  • Pregnancy or lactation
  • Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Cheung CL, Ho DK, Sing CW, Tsoi MF, Cheng VK, Lee GK, Ho YN, Cheung BM. Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese. Sci Rep. 2017 Jan 24;7:41084. doi: 10.1038/srep41084.

MeSH Terms

Conditions

Dyslipidemias

Interventions

Diet, Fat-Restricted

Condition Hierarchy (Ancestors)

Lipid Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Cheung Bernard Man Yung

    Li Ka Shing Faculty of Medicine, The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sun Chieh Yeh Heart Foundation Professor in Cardiovascular Therapeutics

Study Record Dates

First Submitted

August 26, 2015

First Posted

September 4, 2015

Study Start

August 1, 2015

Primary Completion

September 1, 2015

Study Completion

September 1, 2015

Last Updated

October 14, 2015

Record last verified: 2015-10